Topic: H1n1 Marketing

The hosts analyze a shift in the marketing of the shingles vaccine. After reports indicated low uptake among seniors, mainstream media outlets like USA Today began reporting a "short supply" of the vaccine. The hosts argue this is a manufactured PR tactic to create artificial demand, comparing it to previous strategies used for the H1N1 swine flu vaccine.

The Centers for Disease Control and Prevention is conducting a nationwide telephone survey targeting parents of children under three years old. The survey asks detailed questions about H1N1 flu shots, breastfeeding habits, and household income, which the hosts characterize as intrusive market research.

VeriChip Corporation shares tripled in value following the announcement of an exclusive license for patents related to implantable virus detection systems. The technology aims to detect H1N1 and other biological threats within the human body, sparking concerns about surveillance and the "mark of the beast."

Adam Curry analyzes internal CDC marketing documents and PDFs regarding the H1N1 (swine flu) vaccination campaign. He highlights specific "key messages" intended for news media distribution, noting the government's focus on social media and proactive reporting of adverse events. The hosts characterize these communication efforts as state-sponsored propaganda designed to sell vaccines to the public.